Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | TACR2 | P21452 | 1/20 | 0.49 |
| ▸ | TACR1 | P25103 | 1/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 2/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD1 | P21728 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
| ▸ | DRD5 | P21918 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11291802 | 0.99 | HTR2A (0.50) | HTR2ATACR2TACR1SIGMAR1RAB9A | |
| SCHEMBL11281625 | 0.93 | HTR2A (0.52) | HTR2ATACR2TACR1SIGMAR1RAB9A | |
| Hydrochloric Acid SCHEMBL11291237 | 0.92 | HTR2A (0.51) | HTR2ATACR2TACR1SIGMAR1RAB9A | |
| SCHEMBL11286318 | 0.89 | HTR2A (0.49) | HTR2ATACR2TACR1SIGMAR1RAB9A | |
| SCHEMBL11282509 | 0.88 | SIGMAR1 (0.64) | HTR2ATACR2TACR1SIGMAR1RAB9A | |
| SCHEMBL18719630 | 0.88 | TACR2 (0.62) | HTR2ATACR2TACR1SIGMAR1 | |
| Hydrochloric Acid SCHEMBL11280625 | 0.87 | SIGMAR1 (0.63) | HTR2ATACR2TACR1SIGMAR1RAB9A | |
| SCHEMBL11362813 | 0.86 | TACR2 (0.62) | TACR2TACR1 | |
| SCHEMBL18719628 | 0.83 | SIGMAR1 (0.67) | HTR2ATACR2TACR1SIGMAR1DRD3 | |
| SCHEMBL11368445 | 0.81 | TACR2 (0.63) | TACR2TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0061333-A1 | 9-(2-(3-Indolyl)ethyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones | SYNTEX (U.S.A.) INC. (US) | 1982-09-29 | — | — | EP | claimed |
| US-4332804-A | TREATMENT OF HYPERTENSION, CONGESTIVE HEART FAILURE, ARRHYTHMIA, MIGRAINE, VASOSPASTIC DISORDERS AND ASTHMA | SYNTEX (U.S.A.) INC. (US) | 1982-06-01 | — | — | US | claimed |